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Abstract 
BACKGROUND: A new simple, selective and accurate high-performance liquid chromatographic (HPLC) method 
utilising solid-phase extraction for the determination of pantoprazole in human plasma samples has been 
developed.  
AIM: The purpose of this paper was developing a new HPLC method suitable for the determination of 
pantoprazole in plasma samples, which enables simple and rapid isolation and concentration of the analysed 
drug. 
METHODS: The chromatographic separation was accomplished on a LiChroCart LiChrospher 60 RP select B 
column using a mobile phase composed of 0.2 % (V/V) water solution of triethylamine (pH 7) and acetonitrile 
(58:42, V/V) followed by UV detection was at 280 nm. The solid-phase extraction method using LiChrolut RP-18 
(200 mg, 3 ml) was applied to the obtained good separation of investigated drug from endogenous plasma 
components. Best results were achieved when plasma samples were buffered with 0.1 mol/L KH2PO4 (pH 9) 
before extraction, eluted and reconstituted with acetonitrile and 0.001 mol/L NaOH after extraction, respectively.  
RESULTS: The standard calibration curves showed good linearity within the range of 25.0-4000.0 ng/mL with a 
correlation coefficient greater than 0.996. Retention times of pantoprazole and internal standard, lansoprazole 
was 4.1 and 6.0 min respectively. The limit of quantification was 25.0 ng/mL.  For intra- and inter-day precision 
relative standard deviations ranged from 4.2 to 9.3%. The relative errors for stability investigations were ranged 
from 0.12 to -10.5%.  
CONCLUSION: This method has good precision and accuracy and was successfully applied to the 
pharmacokinetic and bioequivalence study of 40 mg pantoprazole in healthy volunteers. 
 
 
 
 
 
 
Introduction 
 
Pantoprazole is a proton pump inhibitor used 
as the first-line treatment for patients with acid-peptic 
disorders, including erosive gastro-oesophageal reflux 
disease, nonerosive reflux disease and duodenal 
gastric ulcers. There are several investigations 
concerning the determination of pantoprazole in 
human plasma samples by high-performance liquid 
chromatography (HPLC). In the published methods, 
liquid-liquid extraction has been used for sample 
preparation [1], [2], [3], [4] using different solvents. 
The disadvantage of these methods employing liquid-
liquid extraction (with grate chemicals consumption) is 
that they involve several steps which can yield poor 
separation from the endogenous plasma 
interferences, these methods are time-consuming 
(usually up to 1 h) regarding multiple steps of 
extraction, drying etc. Some authors proposed 
methods for determination of pantoprazole in human 
plasma using deproteinisation as sample preparation 
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method with acetonitrile or methanol [5], [6], [7], [8], 
single or automated on-line solid-phase extraction 
method [9], [10], [11], [12] or method by direct 
injection [13]. The solid-phase extraction method is 
less labour intensive due to the mechanism which 
allows extraction of the components in a single 
loading step. In comparison with liquid-liquid 
extraction, solid-phase extraction is better suited to 
enriching the concentration of the investigated 
components in plasma samples and not susceptible to 
problematic emulsions. 
In this paper, we describe a new HPLC 
method suitable for the determination of pantoprazole 
in plasma samples employing solid phase extraction 
for sample preparation, which enables simple and 
rapid isolation and concentration of the analysed drug. 
This method is advantageous because of its 
simplicity, efficient clean-up of the complex biological 
matrix and shorter time of analysis, and it is suitable to 
monitor plasma concentrations during clinical 
pharmacokinetic studies in humans.  
 
 
Methods 
 
Chemicals and standards 
Pantoprazole working standard and internal 
standard lansoprazole was supplied by Krka, d.d., 
Novo Mesto, Slovenia. HPLC grade methanol and 
acetonitrile were purchased from Across Organics, 
Belgium. Triethylamine, o-phosphoric acid, sodium 
hydroxide, potassium dihydrogen phosphate and 
columns for solid phase extraction (LiChrolut RP-18, 
40-63 m, 200 mg, 3mL) were obtained from Merck 
(Germany).  
 
Instrumentation and chromatographic 
 conditions 
The method development was performed with 
a High-pressure liquid chromatographic system 
consisting of an autosampler Perkin Elmer LC ISS 
Series 200, an ultraviolet diode array detector (Perkin 
Elmer LC 235 C). The system was controlled, and 
data analysis were performed with the software 
package Turbochrom Version 4.1. Plus, and UV-
spectrometric data were produced by TurboScan 
Version 2.0. The detector was set at 280 nm, and 
peak areas were integrated automatically by using the 
software. Chromatographic separation was carried out 
using LiChroCart LiChrospher 60 RP select B (4.0 mm 
x 250 mm, 5 µm).  
A series of parameters, including composition 
and pH of mobile phase and flow rate, were tested 
concerning the location and shape of the peaks of 
pantoprazole and the internal standard in the 
corresponding chromatograms. The final choice of the 
mobile phase giving satisfying resolution and run time 
was 0.2 % (V/V) triethylamine in water with pH = 7 
and acetonitrile (58:42, V/V). The triethylamine 
solution was prepared by adding 200 L triethylamine 
in 100 mL water and pH of this solution [7] was 
adjusted by concentrated o-phosphoric acid. The 
mobile phase was filtered and degassed with helium 
and delivered at a flow rate of 1.2 mL/min. The 
injection volume was 50 µL. 
 
Preparation of standards 
Stock solutions of 1000 µg/mL of 
pantoprazole and lansoprazole were prepared in 
water and 0.05 mol/L NaOH respectively. These 
solutions were stored at +4°C, and no change in 
stability over 1 month was observed. The working 
solutions were prepared freshly every day by diluting 
appropriate portions of these solutions with water. 
 
Sample preparation  
Human plasma was prepared from 
heparinised whole blood samples. Blood samples 
were collected from healthy volunteers and stored at -
20°C. After thawing, samples were spiked daily with 
stock solutions of pantoprazole and lansoprazole as 
an internal standard.  
A 12 ports solid-phase extraction vacuum 
manifold (Merck) was used for sample preparation. A 
single extraction with LiChrolut RP-18 (40-63 m) 200 
mg, 3 mL standard PP-tubes was used to isolate the 
drug and internal standard from plasma samples. The 
cartridge was conditioned sequentially by elution with 
2 mL methanol and 2 mL water. Spiked plasma 
sample (total volume 1.05 mL, 1 mL spiked plasma 
with pantoprazole and 0.05 mL internal standard) was 
buffered with 1 mL of 0.1 mol/L KH2PO4 (pH 9) and 
was introduced into the cartridge under vacuum at 5 
psi. Water (2 mL) was used to rinse the cartridge. 
Elution was then performed with 0.7 mL of acetonitrile. 
This eluate was collected in a clean tube and was 
evaporated to dryness under N2 for about 20 min at 
40°C. After the reconstitution of the residue with 200 
L of 0.001 mol/L NaOH, a 50 L volume was injected 
into the HPLC system.  
 
Calibration curves 
Typical calibration curves were constructed 
with six blank plasma samples spiked with appropriate 
amounts of the standard solutions. The calibration 
range was 25.0-4000.0 ng/mL of pantoprazole. The 
standard samples were prepared according to the 
procedure as unknown samples. Content of 
pantoprazole in control and unknown samples was 
determined by an internal standard method using 
weighted (1/c) calibration curves obtained by plotting 
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peak height ratios of pantoprazole and the internal 
standard against pantoprazole concentration. 
 
Method validation 
The proposed method was validated by 
evaluating selectivity, precision, accuracy, linearity, 
sensitivity, ruggedness and stability according to 
guidelines for Bioanalytical Method Validation, 
European Medicines Agency, Committee for Medicinal 
Products for Human Use, 2009 [14]. The selectivity of 
the proposed method was determined by comparing 
the chromatograms of diluent, standard solutions, 
blank plasma and spiked plasma samples. Intra-day 
precision values were assessed by calculating the 
relative standard deviation (RSD) for eight replicates 
at three different concentrations spiked into blank. 
Inter-day precision was assessed by measuring two 
individually prepared spiked plasma samples at three 
different concentration levels of pantoprazole in 6 
different days. Accuracy (intro- and inter-) was 
determined by calculating relative error (%). 
Ruggedness was performed on the second HPLC 
column of the same type by injecting a standard 
solution of pantoprazole and internal standard. 
Relative error was calculated by comparing the mean 
peak height for both substances to those obtained by 
changing pH value of the mobile phase from 7.0 to 7.3 
and from 7.0 to 6.7 or to those obtained by changing 
the detection wavelength from 280 nm to 275 nm and 
from 280 nm to 285 nm. Stability of pantoprazole in 
plasma was evaluated for 2, 12 and 24 hours, after 
one and three freeze/thaw cycles and after 1 month 
stored at -20°C using spiked samples at two different 
concentration levels prepared in duplicate.  
 
 
Results  
 
Method development 
Our objectives for this work were to develop a 
robust, rapid and reproducible analytical assay for 
pantoprazole in human plasma using HPLC-UV which 
after validation would be appropriate for application in 
a clinical study evaluating the bioequivalence of 
various pantoprazole formulations. Therefore, a series 
of studies were conducted to develop a convenient 
and easy-to-use method for quantitative analysis of 
pantoprazole in plasma samples. Several HPLC 
method variables concerning their effect on the 
separation of pantoprazole and internal standard from 
the matrix, reducing run time and maximising 
resolution were investigated.  
In our extensive preliminary experiments, a 
series of aqueous mobile phases containing buffer 
solutions with different pH values in combination with 
different modifiers including acetonitrile, 2-propanol 
and triethylamine with different volume fractions were 
tested. The presence of triethylamine in the mobile 
phase improved peak shape and increased the 
intensity of the observed pantoprazole signal. The 
results were most satisfactory when the mobile phase 
consisted of 0.2% (V/V) triethylamine in water with pH 
7 and acetonitrile in volume fractions 58:42. A set of 
column packing including C8, C18 and RP select B 
with different lengths and particle sizes were tested 
and the LiChroCart LiChrospher 60 RP select B 
packing showed the best separation. The total 
chromatographic run time is 7 min, which is amenable 
to the high-throughput requirements of clinical study 
analyses. A typical chromatogram of standard 
solutions of pantoprazole and internal standard 
produced by the developed HPLC method is shown in 
Figure 1c. The retention time of pantoprazole and 
internal standard (lansoprazole) are 4.1 min and 6.0 
min, respectively.  
Also, to obtain satisfactory values for recovery 
of pantoprazole different cartridges for solid phase 
extraction were tested. The satisfactory values for 
recovery of pantoprazole and internal standard were 
obtained when solid phase extraction is performed on 
LiChrolut RP-18 tubes.  
Also, to improving the extraction procedure, 
plasma samples were buffered with 1.0 mL of 0.1 
mol/L KH2PO4 solution (pH 9) before introducing into 
the cartridges.  
 
Figure 1: Chromatograms of A) diluent; B) blank plasma; C) 
standard solutions of pantoprazole and internal standard; D) spiked 
plasma sample with pantoprazole and lansoprazole 
 
Under the chromatographic conditions 
described, pantoprazole and the standard internal 
peaks were well resolved. Endogenous plasma 
components did not give any interfering peaks. 
Typical chromatograms of blank plasma in 
comparison to spiked sample are shown in Figure 1b 
and 1d). On the other hand, the method in this report 
has sufficient sensitivity and reproducibility to permit 
the pharmacokinetic studies. The developed HPLC 
method can be used for the analysis of plasma 
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samples from healthy volunteers after oral 
administration of 40 mg pantoprazole. A typical 
chromatogram of a plasma sample of a patient after 
administration of 40 mg pantoprazole is shown in 
Figure 2. Chromatograms showed no interfering peak 
at the pantoprazole and internal standard peaks 
position.  
 
 
Figure 2: Chromatogram of plasma sample of a patient after 
administration of 40 mg pantoprazole (2h post-dose, the 
concentration of pantoprazole 2023.7 ng/mL) 
 
Linearity 
The method was validated using a six-point 
calibration curve ranging from 25.0 to 4000.0 ng/mL of 
pantoprazole. Respective weighted (1/c) linear 
regression equation was: y = 0.001726 · + 0.020017. 
The correlation coefficient was routinely greater than 
0.996.  
 
Precision and accuracy 
Intra-day precision and accuracy were 
determined by measuring individually prepared eight 
spiked plasma samples at three different 
concentration levels of pantoprazole, first near LOQ. 
Inter-day precision and accuracy were investigated by 
analysing 2 series of spiked plasma samples at low, 
middle and high concentration levels of pantoprazole 
in six different days. Then, the corresponding relative 
standard deviation and relative errors were calculated. 
The data for intro- and inter-day precision and 
accuracy of the proposed method are shown in Table 
1. As can be seen from results presented in Table 1, 
for intra- and inter-day precision, RSDs ranged from 
4.2 to 8.9% and from 4.9 to 9.3%, respectively. These 
data indicate a considerable degree of precision and 
reproducibility for the method both during one 
analytical run and between different runs. 
Relative errors at all three concentrations 
studied are less than 7.0% for intra-day accuracy and 
7.3% for inter-day accuracy, and it is obvious that the 
method is remarkably accurate, which ensures 
obtaining reliable results. 
 
The lower limit of quantification 
The lower limit of quantification was defined 
as the lowest concentration of pantoprazole on the 
standard curve, which can be measured with 
acceptable accuracy and precision (RSD less than 
20%, relative error ± 20 %, n = 6) [14]. The LLOQ was 
estimated using the lowest calibration standard in six 
different analytical days. Pantoprazole concentration 
of 25 ng/mL was accepted as LLOQ.  
Table 1: Intra-and inter-day precision and accuracy data 
Pantoprazole 
nominal 
concentration 
(ng/mL) 
Intra-day Inter-day 
Mean (n = 8) 
observed 
concentration 
(ng/mL) 
Relative 
standard 
deviation (%) 
Mean (n = 12) 
observed 
concentration 
(ng/mL) 
Relative 
standard 
deviation (%) 
Precision 
50.0 47.1 8.9 46.3 9.3 
750.0 697.5 7.0 743.2 5.3 
2500.0 2487.7 4.2 2418.3 4.9 
Accuracy  Relative error 
(%) 
 Relative error 
(%) 
50.0 
750.0 
2500.0 
47.1 
697.5 
2487.7 
-5.9 
-7.0 
-0.5 
46.3 
743.2 
2418.3 
-7.3 
-0.9 
-3.3 
 
 
Stability of pantoprazole in blood samples 
Stability investigation of pantoprazole in 
plasma samples was performed by analysing two 
series of spiked samples at two different concentration 
levels (50 and 2500 ng/mL) after different storage 
conditions: immediately, after staying in an 
autosampler for 2, 12 and 24 hours, after one and 
three freeze/thaw cycles and after 1 month stored at -
20°C. Samples were analysed against a calibration 
curve, obtained from freshly spiked calibration 
standards, and the obtained concentrations are 
compared to the nominal concentrations. The relative 
errors were calculated and for stability investigations 
after 2, 12 and 24 hours ranged from 0.12 to -10.5%, 
after one and three freeze/thaw cycles ranged from -
2.76 to 7.88% and for after 1 month stored at -20°C 
ranged from 0.48 to 4.5%.  
 
 
Discussion 
 
The results from this investigation show that 
pantoprazole added to plasma samples is stable in 
the different storage conditions if we are taking into 
account that the criterion is mean concentration at 
each level should be within ± 15% of the nominal 
concentration [14]. 
In conclusion, the proposed HPLC method 
employing solid-phase extraction for sample 
preparation is simple and convenient for the 
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determination of pantoprazole in plasma samples and 
the total run time for the chromatographic run is less 
than 7 minutes. The validation data demonstrate good 
precision and accuracy, which proves the reliability of 
the proposed method. The quantitation of 
pantoprazole was not affected by any of the possible 
matrix interfering substances. In conclusion, this 
paper describes a very simple and sensitive HPLC 
method for the determination of pantoprazole suitable 
to monitor plasma concentrations during clinical 
pharmacokinetic studies in humans.  
 
 
References 
 
1. Bharathi DV, Hotha KK, Jagadeesh B, Chatki PK, Thriveni K, 
Mullangi R, Naidu A. Simultaneous estimation of four proton pump 
inhibitors--lansoprazole, omeprazole, pantoprazole and 
rabeprazole: development of a novel generic HPLC-UV method 
and its application to clinical pharmacokinetic study. Biomed 
Chromatogr. 2009; 23(7):732-9. https://doi.org/10.1002/bmc.1177 
PMid:19360758  
2. Noubarani M, Keyhanfar F, Motevalian M, Mahmoudian M. 
Improved HPLC method for determination of four PPIs, 
omeprazole, pantoprazole, lansoprazole and rabeprazole in human 
plasma. J Pharm Pharm Sci. 2010; 13(1):1-10. 
https://doi.org/10.18433/J3GP4Q PMid:20456825  
 
3. Emami J, Rezazadeh M, Kalani M. Quantification of 
pantoprazole by high performance liquid chromatography (HPLC) 
method: In vitro and in vivo applications. Journal of Liquid 
Chromatography & Related Technologies. 2014; 37(5):681-95. 
https://doi.org/10.1080/10826076.2012.758137 
 
4. Ramakrishna NV, Vishwottam KN, Wishu S, Koteshwara M. 
High-performance liquid chromatography method for the 
quantification of pantoprazole in human plasma. J Chromatogr B 
Analyt Technol Biomed Life Sci. 2005; 822(1-2):326-9. 
https://doi.org/10.1016/j.jchromb.2005.06.011 PMid:16005696  
 
5. Battu PR, Reddy NK. Development and validation of RP-HPLC 
for the pantoprazole sodium sesquihydrate in pharmaceutical 
dosage forms and human plasma. International Journal of 
ChemTech Research. 2009; 1(2):195-8. 
 
6. Li Y, Ding MJ, Ma J, Wang S, Wu XL, Xu HJ, Lu ZY, Zou JJ, Fan 
 
HW, Zhou XM. Quantification of pantoprazole in human plasma 
using LC-MS/MS for pharmacokinetics and bioequivalence study. 
Eur J Drug Metab Pharmacokinet. 2011; 35(3-4):147-55. 
https://doi.org/10.1007/s13318-010-0018-5 PMid:21302042  
7. Zarghi A, Shafaati A, Foroutan SM, Movahed H, Khoddam A. A 
rapid high-performance liquid chromatographic method for the 
determination of pantoprazole in plasma using UV detection. 
Application in pharmacokinetic studies. Arzneimittelforschung. 
2008; 58(9):441-4. https://doi.org/10.1055/s-0031-1296536 
PMid:18972873  
 
8. Koçyiğit-Kaymakçoğlu B, Unsalan S, Rollas S. Determination 
and validation of ketoprofen, pantoprazole and valsartan together 
in human plasma by high performance liquid chromatography. 
Pharmazie. 2006; 61(7):586-9. 
 
9. Storms ML, Stewart JT. Development of a reversed-phase liquid 
chromatographic method for the analysis of amoxicillin, 
metronidazole, and pantoprazole in human plasma using solid-
phase extraction. Journal of liquid chromatography & related 
technologies. 2002; 25(16):2433-43. https://doi.org/10.1081/JLC-
120014265 
 
10. Tanaka M, Yamazaki H. Direct determination of pantoprazole 
enantiomers in human serum by reversed-phase high-performance 
liquid chromatography using a cellulose-based chiral stationary 
phase and column-switching system as a sample cleanup 
procedure. Anal Chem. 1996; 68(9):1513-6. 
https://doi.org/10.1021/ac951127n PMid:8815744  
 
11. Srinandan V, Nagappan K, Patel S, Yamjala K, Byran G, Babu 
B. Simultaneous Quantification of Pantoprazole and Levosulpiride 
in Spiked Human Plasma Using High Performance Liquid 
Chromatography Tandem Mass Spectrometry. Current 
Pharmaceutical Analysis. 2019; 15(1):17-23. 
https://doi.org/10.2174/1573412914666180101142646 
 
12. Dotsikas Y, Apostolou C, Soumelas S, Kolocouri F, Ziaka A, 
Kousoulos C, Loukas YL. Validation of a novel, fully automated 
high throughput high-performance liquid chromatographic/tandem 
mass Spectrometric method for quantification of pantoprazole in 
human plasma. J AOAC Int. 2010; 93(4):1129-36. 
 
13. Cass QB, Degani AL, Cassiano NM, Pedrazolli J Jr. 
Enantiomeric determination of pantoprazole in human plasma by 
multidimensional high-performance liquid chromatography. J 
Chromatogr B Analyt Technol Biomed Life Sci. 2002; 766(1):153-
60. https://doi.org/10.1016/S0378-4347(01)00472-8 
 
14. EMEA/CHMP/EWP/192217/2009 Rev.1 Corr.2. Guideline on 
Bioanalytical Method Validation. London, July 2011.  
 
